It was a moment of maximum peril for Astrazeneca. The British drugs giant was laid low and attempting a turnaround, but the raiders were at the gate. Smelling an opportunity, American rival Pfizer swooped with a £69billion takeover bid which bosses hoped would cut costs and shrink its tax bills. But in the ensuing struggle, … Read more
Trials for AstraZeneca’s new ‘antibody cocktail’ treatment will begin in the UK – and it could prevent Covid-19 from developing for up to a year. A participant in Manchester will be the first in the world to receive the pharmaceutical company’s new ‘antibody cocktail’ as part of the trial to test its effectiveness. The clinical … Read more
Pfizer‘s coronavirus vaccine could cost Britain £588million and wind up being seven times more expensive per dose than the one being developed by Oxford University. The jab, which the company this week claimed is 90 per cent effective and could be approved by regulators within weeks, is likely to cost at least £15 per dose … Read more
US regulators said on Wednesday that AstraZeneca can resume the US arm of its trial of Oxford University’s coronavirus vaccine, according to documents obtained by the Wall Street Journal. AstraZeneca paused global trials on September 8 due to what it called at the time an ‘unexplained illness’ in a British volunteer. Tests resumed on September … Read more
Dr João Pedro R. Feitosa (pictured), a 28-year-old from Rio De Janeiro, Brazil, was confirmed to be the volunteer who died in the Brazilian arm of AstraZeneca and the University of Oxford’s coronavirus vaccine trial A volunteer in the Brazilian arm of AstraZeneca and the University of Oxford’s coronavirus vaccine trial has died, the country’s health … Read more
A volunteer in the Brazilian arm of AstraZeneca and Oxford University’s coronavirus vaccine trial has died. Brazilian health authority Anvisa stated on Wednesday that it had just received information from an investigation into the death. The Federal University of São Paulo, which is helping coordinate phase III clinical trials in Brazil, separately said that the … Read more
Astrazeneca’s US Covid trial to resume after regulators fail to link patient’s illness with the vaccine By Daily Mail City & Finance Reporter Published: 22:12 BST, 20 October 2020 | Updated: 22:32 BST, 20 October 2020 Astrazeneca’s large, late-stage US trial has been on hold since September 6 Astrazeneca’s Covid-19 vaccine trial in the United … Read more
US widens probe into Astrazeneca’s Covid jab after patient develops rare spinal disorder during trials By Daily Mail City & Finance Reporter Published: 21:52 BST, 1 October 2020 | Updated: 22:05 BST, 1 October 2020 A probe into how a patient became ill during trials of Astrazeneca’s potential Covid-19 jab has been widened in the … Read more
US regulators are ‘very concerned’ about the potential side effects of AstraZeneca and Oxford University’s coronavirus vaccine and are debating whether or not to allow the trials to resume. Last week, the trial was put on hold when a British participant was rushed to the hospital after suffering a serious reaction that triggered spinal cord … Read more
Trials of Oxford University’s coronavirus vaccine could be allowed to restart just days after a British volunteer was rushed to hospital with suspected swelling in their spinal cord. UK drug giant AstraZeneca, which owns the rights to the vaccine, announced that all studies of the jab had been paused indefinitely while it investigates whether the … Read more